We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$763M
AUM Growth
+$39.8M
Cap. Flow
+$772K
Cap. Flow %
0.1%
Top 10 Hldgs %
72.89%
Holding
32
New
5
Increased
8
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$19M
2
CMRX
Chimerix, Inc.
CMRX
+$12.5M
3
ABEO icon
Abeona Therapeutics
ABEO
+$9.64M
4
VANI icon
Vivani Medical
VANI
+$6.27M
5
BIOL
Biolase, Inc.
BIOL
+$5.16M

Top Sells

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$29.3M
2
MZOR
Mazor Robotics Ltd.
MZOR
+$12.2M
3
RPRX
Repros Therapeutics Inc.
RPRX
+$10M
4
OPK icon
Opko Health
OPK
+$4.19M
5
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$2.72M

Sector Composition

Rank Sector Weight
1 Healthcare 80.64%
2 Consumer Staples 0.43%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$104M 13.65%
542,589
– –
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$84.3M 11.06%
2,915,633
– –
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$67.3M 8.83%
3,754,343
– –
THC icon
4
Tenet Healthcare
THC
$22.6B
$65.5M 8.59%
1,292,392
-11,825
-0.9% -$618K
OPK icon
5
Opko Health
OPK
$1.25B
$52.5M 6.89%
5,258,886
-489,878
-9% -$4.19M
ACOR
6
DELISTED
Acorda Therapeutics
ACOR
$42.2M 5.53%
8,606
-6,820
-44% -$29.3M
THOR
7
DELISTED
THORATEC CORPORATION
THOR
$40M 5.25%
1,232,600
+10,600
+0.9% +$308K
CMRX
8
DELISTED
Chimerix, Inc.
CMRX
$39M 5.12%
969,400
+369,400
+62% +$12.5M
TTHI
9
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$33.2M 4.36%
4,861,321
+10,000
+0.2% +$64.6K
ARAY icon
10
Accuray
ARAY
$29M
$27.6M 3.62%
3,657,700
+10,791
+0.3% +$76.1K
BIOL
11
DELISTED
Biolase, Inc.
BIOL
$27.5M 3.6%
838
+165
+25% +$5.16M
MZOR
12
DELISTED
Mazor Robotics Ltd.
MZOR
$26.4M 3.46%
2,125,000
-1,029,281
-33% -$12.2M
PACB icon
13
Pacific Biosciences
PACB
$432M
$25.3M 3.32%
3,230,518
+5,000
+0.2% +$32K
TSRO
14
DELISTED
TESARO, Inc.
TSRO
$20.7M 2.71%
556,379
– –
RPTP
15
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$20.4M 2.68%
+1,942,892
New +$19M
VRML
16
DELISTED
Vermillion, Inc.
VRML
$16.1M 2.11%
8,112,182
+972,222
+14% +$1.52M
HNSN
17
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$14.5M 1.9%
2,602,798
– –
PGEN icon
18
Precigen
PGEN
$1.97B
$10.1M 1.33%
385,574
– –
WBMD
19
DELISTED
WebMD Health Corp.
WBMD
$9.42M 1.23%
238,103
-13,995
-6% -$538K
ABEO icon
20
Abeona Therapeutics
ABEO
$343M
$9.27M 1.22%
+107,476
New +$9.64M
CERS icon
21
Cerus
CERS
$585M
$6.36M 0.83%
+1,018,505
New +$4.62M
AMRN
22
Amarin Corp
AMRN
$293M
$5.08M 0.67%
259,072
-12,678
-5% -$264K
AGEN
23
Agenus
AGEN
$275M
$4.61M 0.6%
59,160
– –
VANI icon
24
Vivani Medical
VANI
$113M
$4.43M 0.58%
+17,983
New +$6.27M
YTEN
25
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$3.28M 0.43%
139
+48
+53% +$1.65M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Oracle Investment Management held 32 positions worth $763M, up 5.5% from $723M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Oracle Investment Management's Q4 2014 filing shows 5 new, 8 increased, 6 reduced and 4 closed positions. Its largest new stake was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 1,942,892 shares worth $20.4M. The largest sale was Acorda Therapeutics, an estimated $29.3M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 79% a quarter earlier, followed by Consumer Staples and Financials.

  • Oracle Investment Management's largest Q4 2014 buy was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 1,942,892 shares worth $20.4M.
  • Oracle Investment Management added most to Chimerix, Inc. in Q4 2014, an estimated $12.5M increase.
  • Oracle Investment Management's biggest Q4 2014 reduction was Acorda Therapeutics, cutting an estimated $29.3M.
  • Oracle Investment Management fully exited Repros Therapeutics Inc. in Q4 2014, selling an estimated $10M.
  • Oracle Investment Management's ten largest holdings make up 73% of its $763M portfolio in Q4 2014.
  • Oracle Investment Management opened 5 new positions and closed 4 in Q4 2014.
  • Oracle Investment Management's portfolio value rose 5.5% quarter-over-quarter to $763M.

Based on Oracle Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.